These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20854187)

  • 21. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
    Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
    Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1).
    Svendsen MN; Werther K; Christensen IJ; Basse L; Nielsen HJ
    Inflamm Res; 2005 Nov; 54(11):458-63. PubMed ID: 16307219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The determination and significance of VEGF in the serum of hemangioma patients].
    Hu Q; Lin X; Shang Q; Dong J; Qi Z; Wang W
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2002 Mar; 18(2):98-100. PubMed ID: 12192772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery.
    Kirman I; Belizon A; Balik E; Feingold D; Arnell T; Horst P; Kumara S; Cekic V; Jain S; Nasar A; Whelan RL
    Eur J Surg Oncol; 2007 Dec; 33(10):1169-76. PubMed ID: 17512160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of smoking and fibrosis in patients with chronic hepatitis C.
    Dev A; Patel K; Conrad A; Blatt LM; McHutchison JG
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):797-801. PubMed ID: 16682255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
    Bakir M; Bakir S; Sari I; Celik VK; Gozel MG; Engin A
    J Med Virol; 2013 Oct; 85(10):1794-801. PubMed ID: 23868816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The change of serum vascular endothelial growth factor and matrix metalloproteinases-9 in proliferative hemangioma treated with propranolol].
    Zhao ZF; Lü RR; Huo R; Fu HB; Xu GQ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Sep; 27(5):359-61. PubMed ID: 22259987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
    Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
    Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas.
    Berard M; Sordello S; Ortega N; Carrier JL; Peyri N; Wassef M; Bertrand N; Enjolras O; Drouet L; Plouet J
    Am J Pathol; 1997 Apr; 150(4):1315-26. PubMed ID: 9094988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients.
    Guo Q; Carrero JJ; Yu X; Bárány P; Qureshi AR; Eriksson M; Anderstam B; Chmielewski M; Heimbürger O; Stenvinkel P; Lindholm B; Axelsson J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3468-73. PubMed ID: 19561151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated plasma levels of tissue factor as a valuable diagnostic biomarker with relevant efficacy for prediction of breast cancer morbidity.
    Zarychta E; Rhone P; Bielawski K; Rosc D; Szot K; Zdunska M; Ruszkowska-Ciastek B
    J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30802214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease.
    Yilmaz Y; Yonal O; Kurt R; Alahdab YO; Ozdogan O; Celikel CA; Ulukaya E; Imeryuz N; Kalayci C; Avsar E
    Arch Med Res; 2011 Jan; 42(1):38-43. PubMed ID: 21376261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
    Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
    Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in circulating levels of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 after carotid endarterectomy.
    Papalambros E; Georgopoulos S; Sigala F; Vourliotakis G; Chrisostomidis G; Venetsanou K; Hadjoulis G; Felekouras E; Bastounis E
    Int J Mol Med; 2004 Jul; 14(1):133-6. PubMed ID: 15202028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of circulating vascular endothelial growth factor and its soluble receptors in patients with different forms of chronic urticaria.
    Jagodzinska J; Polaniak R; Birkner E; Kasperska-Zajac A
    Biomed Res Int; 2015; 2015():578383. PubMed ID: 25756047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
    Belgore FM; Blann AD; Lip GY
    Clin Sci (Lond); 2001 May; 100(5):567-75. PubMed ID: 11294698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.